<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="79072">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02092246</url>
  </required_header>
  <id_info>
    <org_study_id>13-008328</org_study_id>
    <nct_id>NCT02092246</nct_id>
  </id_info>
  <brief_title>Ultrasound Guided vs Unguided Intra-articular Knee Injections</brief_title>
  <official_title>Accuracy of Ultrasound Guided Versus Unguided Intra-articular Knee Injections in a Difficult to Inject Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the accuracy of unguided versus ultrasound (US) guided knee joint injections in
      obese patients with no clinically detectable effusion.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">February 2015</completion_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Accuracy of the initial needle placement into the knee joint.</measure>
    <time_frame>During the initial needle placement, which can take 1-5 minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>The number of participants with accurate initial needle placement into the knee joint</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improved clinical efficacy of US guided knee injections compared to unguided knee injections</measure>
    <time_frame>30 minutes post injection</time_frame>
    <safety_issue>No</safety_issue>
    <description>Comparison of VAS scores 30 minutes after injection between subjects who had ultrasound guided knee injections and those who didn't</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Detection of knee effusions</measure>
    <time_frame>During procedure, which can take up to 30 minutes to complete</time_frame>
    <safety_issue>No</safety_issue>
    <description>Comparison of the accuracy of detecting a knee effusion on clinical examination versus ultrasonographically</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Osteoarthritis</condition>
  <condition>Inflammatory Arthritis</condition>
  <arm_group>
    <arm_group_label>Ultrasound Machine Guided Injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Use of ultrasound machine guidance in needle placement into the knee joint</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Unguided Injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Needle placement performed without ultrasound machine guidance</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound machine</intervention_name>
    <description>Use of ultrasound machine guidance for accurate needle placement into the knee joint</description>
    <arm_group_label>Ultrasound Machine Guided Injection</arm_group_label>
    <other_name>Philips CX-50 Ultrasound Machine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Unguided injection</intervention_name>
    <description>Needle placement will take place without ultrasound machine guidance</description>
    <arm_group_label>Unguided Injection</arm_group_label>
    <other_name>Philips CX-50 Ultrasound Machine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  BMI &gt; 30

          -  No clinically detectable knee effusion

          -  Clinical or radiographic evidence of knee osteoarthritis or inflammatory    arthritis

          -  Must be referred to the Pain Clinic for treatment

        Exclusion Criteria

          -  History of surgery on the affected knee

          -  Evidence of untreated systemic infection or systemic immunocompromise

          -  Evidence of cutaneous infections near the study knee injection site

          -  Patients on warfarin with an INR &gt; 3.0

          -  Patients on oral antiplatelet or anticoagulant medications will be excluded if they
             have documented evidence of renal insufficiency (GFR &lt; 60)

          -  History of iodinated contrast allergy or significant reaction to corticosteroids or
             lidocaine
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew Pingree, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 18, 2014</lastchanged_date>
  <firstreceived_date>March 13, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Matthew Pingree</investigator_full_name>
    <investigator_title>Assistant Professor of Physical Medicine and Rehabilitation</investigator_title>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
